Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ParaZero Technologies (PRZO) Cash & Equivalents (2022 - 2025)

ParaZero Technologies (PRZO) has disclosed Cash & Equivalents for 4 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 48.33% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 48.33% year-over-year, with the annual reading at $2.2 million for FY2025, 48.33% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $2.2 million at ParaZero Technologies, down from $4.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $7.4 million in Q4 2023, with the low at $89806.0 in Q4 2022.
  • Average Cash & Equivalents over 4 years is $3.5 million, with a median of $3.2 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents surged 8171.61% in 2023, then crashed 48.33% in 2025.
  • Over 4 years, Cash & Equivalents stood at $89806.0 in 2022, then soared by 8171.61% to $7.4 million in 2023, then tumbled by 43.74% to $4.2 million in 2024, then plummeted by 48.33% to $2.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $2.2 million, $4.2 million, and $7.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.